We transform Australia & New Zealand's most exciting biomedical research discoveries into new medical products that improve patient outcomes and save lives.

Brandon BioCatalyst is the largest life science investment fund in Australia and New Zealand. We are a unique collaboration between major Australian superannuation funds, CSL, the Australian and New Zealand governments, Australian state governments and more than 50 leading medical research institutes and research hospitals.

Learn more about who we are
CUREator is an Australian national biotechnology incubator supporting the development of pre-clinical and clinical stage medical innovation.

Portfolio

We’re immensely proud of our portfolio. Partnering with talented scientists, clinicians and entrepreneurs, we have supported more than 50 companies to date.

Vaxxas
Vaxxas

Vaxxas' proprietary Nanopatch™ technology is a needle-free vaccine delivery solution

View Project
CatalYm
CatalYm

Reversing GDF-15-mediated immunosupression to induce anti-tumour responses

View Project
Entact Bio
Entact Bio

Developing a new class of therapeutics that enhance the function of beneficial proteins

View Project
Developing disease-modifying mitochondrial therapeutics for neurodegenerative disorders
Developing disease-modifying mitochondrial therapeutics for neurodegenerative disorders

View Project
Pheon Therapeutics
Pheon Therapeutics

Developing first-in-class ADCs to treat cancer

View Project
TamoRx
TamoRx

Developing novel immuno-oncology small molecule inhibitors

View Project
Amaroq Therapeutics
Amaroq Therapeutics

Targeting long non-coding RNAs for next generation cancer therapies

View Project
Currus Biologics
Currus Biologics

Developing the next generation of CAR-T cell therapies to treat solid cancers

View Project
See all

Members

Brandon BioCatalyst brings together more than 50 leading medical research institutes across Australia and New Zealand.

Institute
Harry Perkins Institute of Medical Research

Since 1998, the Harry Perkins Institute of Medical Research has grown to become one of the nation’s leading adult medical research centres, where a close-knit team of more than 400 research and trial staff work together to defeat the major diseases that impact our community. Our teams investigate a wide range of diseases, with a strong focus on cancer, cardiovascular disease, diabetes and neurogenetic diseases. Our world-class scientists, doctors and researchers are inspired to pursue vital research initiatives to build a healthier future for everyone.

View
Institute
Auckland Cancer Society Research Centre

Since its inception in 1956, the Auckland Cancer Society Research Centre (ACSRC) has published nearly 1,000 papers in international scientific and medical journals, and filed more than 100 patent applications for new anti-cancer drugs.

View
Institute
ithree institute

The ithree institute brings together a team of scientists with diverse skill sets who collectively address key challenges in the understanding and control of infectious diseases in humans and animals. Our senior scientists have recently refined the key research themes under which they will work together to increase their impact in the antibiotic resistance, food safety and infectious disease space.

View

Membership

Brandon BioCatalyst is innovation in action: We provide a path for taking medical science from conception into the real world.

Our Venture capital model is unique. We don’t simply provide investment, we partner with entrepreneurs to create businesses, run companies and everything necessary to ensure our investments succeed.

Learn more